A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2009
11/25/2009	EP1017275B1 Polyamine treatment of neurological disorders
11/25/2009	CN201349837Y Health pillow core
11/25/2009	CN101589060A Methods of treating pain and inflammation in neuronal tissue using il-31 antagonists
11/25/2009	CN101589056A Depsipeptides and their therapeutic use
11/25/2009	CN101589046A Azaspiro derivatives
11/25/2009	CN101589042A Pharmacologically active n,n'-substituted 3,7-diazabicyclo [3.3.1] nonanes, pharmaceutical compositions based thereon and a method for the use thereof
11/25/2009	CN101589037A Heteromonocyclic compound and use thereof
11/25/2009	CN101589029A 1,2,3-triazole derivatives as sigma receptor inhibitors
11/25/2009	CN101588802A Skin adhesive preparation comprising stabilized donepezil
11/25/2009	CN101586096A Recombinant virus with coexpression of anthropogenic glutamate decarboxylase and cell factor
11/25/2009	CN101585881A An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/25/2009	CN101585862A Novel steroids
11/25/2009	CN101585800A Bis(indolyl)methane compound with bioactivity
11/25/2009	CN101585799A Method for preparing unsymmetrical bis(indolyl)methane compound
11/25/2009	CN101585779A New crystal form of Agomelatine, preparation method and use thereof
11/25/2009	CN101585778A Lyrica preparation method
11/25/2009	CN101585777A Method for preparing a Venlafaxine hydrochloride crystal FORMULA
11/25/2009	CN101585506A Prescription of acanthopanax health preserving pillow and child cloth toy filling material
11/25/2009	CN101584869A Method of differentiating/inducing bone marrow interstitial cells into nerve cells and skeleton muscle cells by transferring notch gene
11/25/2009	CN101584867A Methods and compositions for enhanced delivery of bioactive molecules
11/25/2009	CN101584851A Pharmaceutical composition for kidney nourishing, heart calming and nerve calming
11/25/2009	CN101584837A Traditional Chinese medicine for treating schizophrenia and treating the side effect caused by antipsychotics and preparation method thereof
11/25/2009	CN101584822A Composition for quitting smoking and preparation method thereof
11/25/2009	CN101584813A Traditional Chinese medicine for treating facial paralysis
11/25/2009	CN101584796A Application of traditional Chinese medicine composition in preparing medicament for treating melancholia
11/25/2009	CN101584774A Application of compound thrombus-invigorating capsule for preparation of medicament for treating cerebrovascular disease
11/25/2009	CN101584772A Traditional Chinese medicine for treating diabetes surrounding nerve lesion
11/25/2009	CN101584748A Method for preparing shizandra active freeze-dried powder and capsules
11/25/2009	CN101584714A Chinese medicament for radically treating epilepsy
11/25/2009	CN101584713A Muscular amino acids and peptides and nucleosides injection and preparing method thereof
11/25/2009	CN101584712A Composite preparation composed of nervonic acid, composite mineral matter and composite vitamin
11/25/2009	CN101584692A Application of L-stopholidine (L-spd) derivative
11/25/2009	CN101584684A Enteric preparation containing stable salts of S-adenosyl-L-methionine and preparation method thereof
11/25/2009	CN101584674A Venlafaxine hydrochloride sustained-release tablet preparation and preparation method thereof
11/25/2009	CN101584673A Levetiracetam tablet and preparation method
11/25/2009	CN101584652A Risperidone sustained-release gel injection and preparation method thereof
11/25/2009	CN101584373A Health tea for treating liver depression of middle and old aged people
11/25/2009	CN100562521C Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase i epsilon
11/25/2009	CN100562520C Imidazole derivatives iii
11/25/2009	CN100562518C Novel arylethene-sulfonamides compounds
11/25/2009	CN100562338C Beta-amyloid-analogue-cell epitop vaccine
11/25/2009	CN100562332C Compound Chinese medicine for treating epilepsy
11/25/2009	CN100562327C Health-care food for improving sleeping and its preparing process
11/25/2009	CN100562320C Crystalline modifications of 2-(3,5-bis-trifluoromethyl-phenyl)-n-[6-(1,1-dioxo-1 lambda 6-thiomorpholin-4-yl)-4-(4-fluoro-2-methyl-phenyl)-pyridin-3-yl]-n-methyl-isobutyramide
11/25/2009	CN100562312C Novel use of peptide compounds for treating dyskinesia
11/24/2009	US7622487 Piperidine derivative, process for producing the same, and use
11/24/2009	US7622483 Administering an aminoindanyl derivative and; a steroid, dopamine receptor agonist or an anticholinergic or antimuscarinic agent; respiratory system disorders, antiallergens, chronic obstructive pulmonary disease, adult respiratory distress syndrome, bronchitis
11/24/2009	US7622461 Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders
11/24/2009	US7622441 Comprising controlled substance and amino acid or polypeptide covalently bound to controlled substance in manner that renders controlled substance pharmacologically inactive; when delivered by oral route controlled substance is released in time-dependent manner by acid hydrolysis and/or enzyme cleavage
11/24/2009	US7622277 suitable as carriers for drugs used for the treatment of diseases of the central nervous system; can penetrate the blood-brain barrier
11/24/2009	US7622272 Treating cell proliferation disease; aberrant fetoplacental growth; cancer
11/24/2009	US7622136 Transparent transdermal nicotine delivery devices
11/24/2009	CA2541832C Substituted 2h-[1,2,4]triazolo[4,3-a]pyrazines as gsk-3 inhibitors
11/24/2009	CA2485926C (imidazol-1-yl-methyl)-pyridazine as nmda receptor blocker
11/24/2009	CA2475712C Nicotinamide derivatives useful as pde4 inhibitors
11/24/2009	CA2451124C Method for the preparation of escitalopram
11/24/2009	CA2445678C Paroxetine controlled release compositions
11/24/2009	CA2443774C Pharmaceutical dopamine glycoconjugate compositions and methods of their preparation
11/24/2009	CA2422017C A transdermal electrotransport device for use in electrotransport drug delivery and method for manufacturing same
11/24/2009	CA2421504C 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors
11/24/2009	CA2408144C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/24/2009	CA2403831C Coating and binding agent for pharmaceutical formulations having improved storage stability
11/24/2009	CA2392050C Pharmaceutical formulations containing zolmitriptan
11/24/2009	CA2385882C Tyrosine derivatives
11/24/2009	CA2376870C Method for scavenging radicals with urocanic acid, derivatives and analogues
11/24/2009	CA2362411C Use of fluorinated triazoles for treating affective or attention disorders
11/19/2009	WO2009140649A2 Rab3b for the treatment and prevention of parkinson's disease
11/19/2009	WO2009140575A1 Use of ribose in lessening the clinical symptoms of aberrant firing of neurons
11/19/2009	WO2009140557A2 Modified release tolterodine formulations
11/19/2009	WO2009140361A1 ANTI-PirB ANTIBODIES
11/19/2009	WO2009140275A1 Analogs of propofol, preparation thereof and use as anesthetics
11/19/2009	WO2009140204A2 Selective subtype alpha 2 adrenergic agents and methods for use thereof
11/19/2009	WO2009139880A1 Thioxoisoindoline compounds and compositions and methods of using the same
11/19/2009	WO2009139470A1 Pharmaceutical composition for treatment of fibromyalgia
11/19/2009	WO2009139361A1 Glucocorticoid receptor agonist composed of 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivative having substituted oxy group
11/19/2009	WO2009139298A1 Metastin derivative and use thereof
11/19/2009	WO2009139168A1 Therapeutic agent for pain
11/19/2009	WO2009138802A1 A drilling rig and a method for moving a drilling rig
11/19/2009	WO2009138799A1 Therapeutic uses of 1-cycl0pr0pyl-3 - [3- ( 5 -morpholin- 4 -ylmethyl- 1h-benz0imidaz0l- 2 -yl) -lh-pyrazol-4-yl] -urea
11/19/2009	WO2009138762A2 Therapeutic use of peptides
11/19/2009	WO2009138734A2 Use of opioid compounds in peripheral pain, wound healing and scar formation
11/19/2009	WO2009138416A1 Oxime carbamoyl derivatives as modulators of fatty acid amides hydrolase
11/19/2009	WO2009138393A1 5-[5-[2-(3,5-bis(trifluoromethyl)phenyl)-2-methylpropanoylmethylamino]-4-(4-fluoro-2-methylphenyl)]-2-pyridinyl-2-alkyl-prolinamide as nk1 receptor antagonists
11/19/2009	WO2009137880A1 Use of angiogenin or angiogenin agonists for treating diseases and disorders
11/19/2009	WO2009137879A1 Orally administrable dosage forms comprising angiogenin and uses thereof
11/19/2009	WO2009137871A1 Methods of detecting cells with a disrupted cell membrane, cells infected with a pathogen, dying cells or dead cells
11/19/2009	WO2009121039A3 Administration of benzodiazepine compositions
11/19/2009	WO2009118473A3 Azetidine-derived compounds, preparation method therefor and therapeutic use of same
11/19/2009	WO2009117480A8 Histidine related compounds for identifying and blocking amyloid beta ion channels
11/19/2009	WO2009108376A3 Contrast agents for applications including perfusion imaging
11/19/2009	WO2009105218A3 Propiophenone derivatives
11/19/2009	WO2009098320A3 Macrolides for treating diseases mediated through pde inhibition
11/19/2009	WO2009051824A3 Combination analgesic employing opioid and neutral antagonist
11/19/2009	WO2009040659A3 Benzenesulfonamide compounds and the use thereof
11/19/2009	WO2008128049A3 Tetrahydrobiopterin compositions and methods of measuring
11/19/2009	WO2008109437A3 Compositions comprising derivatives of 3 -phenylpyridazine for treating seizure-related disorders
11/19/2009	US20090286879 Preventive or Therapeutic Drug for Alzheimer-Type Dementia
11/19/2009	US20090286876 Neuroprotective benzoate and benzamide compounds
11/19/2009	US20090286868 2-Amino-2-oxoethyl trans-3-[5-(naphth-1-yl)-1,3-dioxan-2-yl]propyl carbamate; reacting the phenylcarbonate with 2-aminodioxane; fatty acid amido hydrolase (FAAH) inhibitors; analgesics; nervous system disorders; gastrointestinal disorders,; to name just a few
11/19/2009	US20090286867 Compositions and methods of administering doxepin to mucosal tissue

1 ... 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 ... 1833